Wilhelm Stahl

Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA.

Saltigo GmbH engages in the custom synthesis of chemical active ingredients and intermediates. It manufactures intermediates and active ingredients for the crop protection market; pharmaceutical intermediates and active pharmaceutical ingredients for pharmaceutical companies; and fine chemicals for non-life-science applications that include oils and waxes for industrial and cosmetic purposes, scents and aromas for cosmetics and foods, plastic additives for PVC and synthetic rubbers, special adhesives for the footwear industry, and chemicals for manufacturing OLEDs and similar compounds found in flat screens and solar modules. The company was founded in April 2006 and is headquartered in Leverkusen, Germany.

Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany.

Rondaxe Enterprises LLC is a pharmaceutical consulting and development company that offers comprehensive CMC solutions, drug development, manufacturing, and regulatory strategies. The private company is based in Syracuse, NY. The company's services assist organizations in product formulation and CMC solutions.